{
"id":"mk19_b_rm_q077",
"number":77,
"bookId":"rm",
"correctAnswer":"D",
"title":"Question 77",
"stimulus":[
{
"type":"p",
"hlId":"579c44",
"children":[
"A 24-year-old woman is hospitalized for rapidly progressive lower extremity edema and rising serum creatinine level. She is diagnosed with new-onset systemic lupus erythematosus."
]
},
{
"type":"p",
"hlId":"d1cdb4",
"children":[
"On physical examination, blood pressure is 162/94 mm Hg, and pulse rate is 98/min. An erythematous malar rash is present. The metacarpophalangeal joints are swollen bilaterally. Lower extremity edema and facial puffiness are present. The cardiopulmonary examination is normal."
]
},
{
"type":"tag",
"tagName":"table",
"attrs":{
"className":"lab-values table"
},
"children":[
{
"type":"tag",
"tagName":"caption",
"attrs":{
},
"children":[
{
"type":"p",
"hlId":"a462a3",
"children":[
"Laboratory studies:"
]
}
]
},
{
"type":"tag",
"tagName":"tbody",
"attrs":{
},
"children":[
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-1 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"61f3aa",
"class":"cell text l",
"children":[
"C3 complement"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"28d0ed",
"class":"cell text l",
"children":[
"Low"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-2 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"323d2d",
"class":"cell text l",
"children":[
"C4 complement"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"28d0ed",
"class":"cell text l",
"children":[
"Low"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-3 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"f461b2",
"class":"cell text l",
"children":[
" ",
{
"type":"reference-range-link",
"referenceRange":"Creatinine, serum",
"children":[
"Creatinine"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"0f217c",
"class":"cell text l",
"children":[
"1.3 mg/dL (114.9 μmol/L)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-4 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"131f5a",
"class":"cell text l",
"children":[
"Anti–double-stranded DNA antibodies"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"328929",
"class":"cell text l",
"children":[
"Positive"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-5 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"b534b1",
"class":"cell text l",
"children":[
"Antinuclear antibodies"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"d43bb8",
"class":"cell text l",
"children":[
"1:1280 (speckled pattern)"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-6 row-even"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"747c2a",
"class":"cell text l",
"children":[
"Urinalysis"
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"2a0c62",
"class":"cell text l",
"children":[
"3+ protein; 2+ blood; 35 erythrocytes/hpf; no leukocytes; no casts"
]
}
]
}
]
},
{
"type":"tag",
"tagName":"tr",
"attrs":{
"className":"group_1-7 row-odd"
},
"children":[
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellLeft1"
},
"children":[
{
"type":"p",
"hlId":"48b103",
"class":"cell text l",
"children":[
"Spot ",
{
"type":"reference-range-link",
"referenceRange":"Protein-creatinine ratio, urine",
"children":[
"urine protein-creatinine ratio"
]
},
" "
]
}
]
},
{
"type":"tag",
"tagName":"td",
"attrs":{
"className":"labValueCellRight1"
},
"children":[
{
"type":"p",
"hlId":"366bc0",
"class":"cell text l",
"children":[
"600 mg/g"
]
}
]
}
]
}
]
}
]
}
],
"prompt":[
" ",
{
"type":"p",
"hlId":"ab9d96",
"children":[
"Which of the following is the most appropriate diagnostic test to perform next?"
]
},
" "
],
"options":[
{
"letter":"A",
"text":{
"__html":"Brain MRI"
}
},
{
"letter":"B",
"text":{
"__html":"Chest CT"
}
},
{
"letter":"C",
"text":{
"__html":"Echocardiography"
}
},
{
"letter":"D",
"text":{
"__html":"Kidney biopsy"
}
}
],
"keypoints":[
{
"type":"keypoint",
"hlId":"ae5fa5",
"children":[
"Recognized indications for kidney biopsy in patients with systemic lupus erythematosus include glomerular hematuria and/or cellular casts, spot urine protein-creatinine ratio greater than 500 mg/g, or unexplained decrease in estimated glomerular filtration rate."
]
},
{
"type":"keypoint",
"hlId":"dab160",
"children":[
"In patients with lupus nephritis, kidney biopsy results are important for choosing induction therapy and determining prognosis."
]
}
],
"exposition":[
{
"type":"p",
"hlId":"64a156",
"children":[
"The most appropriate diagnostic test to perform next is kidney biopsy (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option D"
]
},
"). This patient has acute systemic lupus erythematosus (SLE) with proteinuria and hematuria concerning for kidney involvement. Her positive results for antinuclear and anti–double-stranded DNA antibodies and depressed serum complement values support this diagnosis. Additional evaluation in patients suspected of having lupus nephritis should include 24-hour urine measurement for quantitation of proteinuria and a kidney biopsy. Patients with SLE with any sign of kidney involvement are candidates for kidney biopsy. Indications include proteinuria greater than 500 mg/24 h, urine protein-creatinine ratio greater than 500 mg/g (especially in the setting of hematuria and/or cellular casts), or unexplained decrease in estimated glomerular filtration rate. Biopsy results are important for choosing induction therapy and determining prognosis."
]
},
{
"type":"p",
"hlId":"150f09",
"children":[
"SLE can cause neuropsychiatric manifestations (cerebritis), including seizure, delirium, psychosis, or stroke, which can be important to identify when choosing management strategies. Brain MRI (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option A"
]
},
") is sensitive for detection of abnormalities associated with cerebritis but can be difficult to interpret. This patient has no symptoms to suggest central nervous system disease, so a brain MRI is less likely to be useful in this case."
]
},
{
"type":"p",
"hlId":"922cc4",
"children":[
"Chest CT (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option B"
]
},
") can be useful for identification of serositis, interstitial lung disease, or pulmonary embolism, which can all be associated with SLE, but this patient has no current cardiopulmonary symptoms or examination abnormalities. CT with contrast poses a risk for contrast-induced nephropathy in this patient with an increased serum creatinine level."
]
},
{
"type":"p",
"hlId":"e8083d",
"children":[
"SLE is associated with pericarditis, pericardial or pleural effusions, and other manifestations of serositis. Echocardiography (",
{
"type":"tag",
"tagName":"b",
"attrs":{
},
"children":[
"Option C"
]
},
") can be useful to assess for the presence and severity of pericarditis and effusions, as well as the possibility of valvular disease. In a patient with a normal cardiopulmonary examination and no cardiac symptoms, echocardiography is less useful for guiding management than is a kidney biopsy."
]
}
],
"relatedSection":"mk19_b_rm_s7_2_3",
"objective":{
"__html":"Diagnose lupus nephritis with a kidney biopsy."
},
"references":[
[
"Fanouriakis A, Kostopoulou M, Cheema K, et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79:713-723. ",
{
"type":"tag",
"tagName":"a",
"attrs":{
"href":"http://www.ncbi.nlm.nih.gov/pubmed/32220834",
"target":"_blank"
},
"children":[
"PMID: 32220834"
]
}
]
],
"hospitalist":true,
"hvc":false,
"peerComparison":{
"A":0,
"B":0,
"C":6,
"D":94,
"E":0
},
"hlIds":[
"579c44",
"d1cdb4",
"a462a3",
"61f3aa",
"28d0ed",
"323d2d",
"28d0ed",
"f461b2",
"0f217c",
"131f5a",
"328929",
"b534b1",
"d43bb8",
"747c2a",
"2a0c62",
"48b103",
"366bc0",
"ab9d96",
"ae5fa5",
"dab160",
"64a156",
"150f09",
"922cc4",
"e8083d"
]
}